Alternative Spliced CD1D Transcripts in Human Bronchial Epithelial Cells

MRC Human Immunology Unit, Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, United Kingdom.
PLoS ONE (Impact Factor: 3.23). 08/2011; 6(8):e22726. DOI: 10.1371/journal.pone.0022726
Source: PubMed


CD1d is a MHC I like molecule which presents glycolipid to natural killer T (NKT) cells, a group of cells with diverse but critical immune regulatory functions in the immune system. These cells are required for optimal defence against bacterial, viral, protozoan, and fungal infections, and control of immune-pathology and autoimmune diseases. CD1d is expressed on antigen presenting cells but also found on some non-haematopoietic cells. However, it has not been observed on bronchial epithelium, a site of active host defence in the lungs. Here, we identify for the first time, CD1D mRNA variants and CD1d protein expression on human bronchial epithelial cells, describe six alternatively spliced transcripts of this gene in these cells; and show that these variants are specific to epithelial cells. These findings provide the basis for investigations into a role for CD1d in lung mucosal immunity.

16 Reads
  • [Show abstract] [Hide abstract]
    ABSTRACT: The epithelium, once considered a simple inert barrier against foreign bodies and responsible merely for maintaining tissue structural integrity, is now viewed as a tissue involved in bona fide immune processes, including homeostasis and during the course of microbial insults. At respiratory alveolar surfaces, epithelial cells and alveolar macrophages interact through the production of surfactant, regulatory cytokines and endogenous antimicrobial molecules, to ensure a non-inflammatory regulatory phenotype. Following microbial infection, this regulatory ‘brake’ is released and these cells participate in the orchestration of pro-inflammatory and adaptive immune mechanisms, leading to the containment of the microbial infection and the restoration of tissue homeostasis. We will review here some of the molecular mechanisms operative in this ‘switch’ from regulatory to effector immune phenotypes.
    Revue Française d Allergologie 04/2012; 52(3):141-144. DOI:10.1016/j.reval.2012.01.029 · 0.25 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: CD1d presents glycolipid antigens to invariant natural killer T (iNKT) cells. The role of CD1d in the development of peptic ulcer and gastric cancer has not been revealed, yet. To clarify the expression of alternatively spliced variants of CD1d in peptic ulcer and gastric cancer. Patients with dyspepsia were selected and divided into three groups of non-ulcer dyspepsia (NUD), peptic ulcer disease (PUD), and gastric cancer (GC), according to their endoscopic and histopathological examinations. H. pylori infection was diagnosed by rapid urease test and histopathology. The expression levels of V2, V4, and V5 spliced variants of CD1d molecule were determined by quantitative Reverse Transcriptase PCR. Relative gene expression levels of V4 were higher in GC patients (n=37) than those in NUD (n=49) and PUD (n=51) groups (p<0.05 and p<0.01, respectively). Moreover, GC patients showed higher expression levels of V5 compared to NUD and PUD groups (p<0.001 and p<0.001, respectively). Positive correlation coefficients were attained between V4 and V5 expression in patients with PUD (r=0.734, p<0.0001) and GC (r=0.423, p<0.01), but not in patients with NUD. Among NUD patients, the expression levels of V4, but not V5, were higher in H. pylori-positive patients than in H. pylori-negative ones (p<0.01). Collectively, both membrane-bound (V4) and soluble (V5) isoforms of CD1d were over-expressed in gastric tumor tissues, suggesting that they are involved in anti-tumor immune responses.
    Iranian journal of immunology : IJI 06/2015; 12(2):129-40. · 0.42 Impact Factor

Preview (3 Sources)

16 Reads
Available from